Your browser doesn't support javascript.
loading
New Devices in Glaucoma.
Chan, Lilian; Moster, Marlene R; Bicket, Amanda K; Sheybani, Arsham; Sarkisian, Steven R; Samuelson, Thomas W; Ahmed, Iqbal Ike K; Miller-Ellis, Eydie; Smith, Oluwatosin U; Cui, Qi N.
Afiliação
  • Chan L; Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.
  • Moster MR; Wills Eye Hospital, 840 Walnut St, Philadelphia, PA, 19107, USA.
  • Bicket AK; Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, Medical School, University of Michigan, 1000 Wall St, Ann Arbor, MI, 48105, USA.
  • Sheybani A; Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8096, St Louis, MO, 63110, USA.
  • Sarkisian SR; Oklahoma Eye Surgeons, 5600 N Portland Ave, Oklahoma City, OK, 73112, USA.
  • Samuelson TW; Minnesota Eye Consultants, University of Minnesota, 909 Fulton St SE, Minneapolis, MN, 55455, USA.
  • Ahmed IIK; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
  • Miller-Ellis E; Prism Eye Institute, Mississauga, Canada.
  • Smith OU; John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA.
  • Cui QN; Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.
Ophthalmol Ther ; 12(5): 2381-2395, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37558818
Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm's canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article